Synthetic peptide

General Information


DRACP ID  DRACP01794

Peptide Name   Synthetic peptide

Sequence  KWKKLLKKPPPLLKKLLKKL

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Calu-6 Lung adenocarcinoma Carcinoma 35% survival rate at 10 µM MTT assay Not available Patent
Calu-6 Lung adenocarcinoma Carcinoma 0% survival rate at 100 µM MTT assay Not available Patent
Jurkat Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia ~60% survival rate at 10 µM MTT assay Not available Patent
Jurkat Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia 0% survival rate at 100 µM MTT assay Not available Patent
SNU-601 Gastric signet ring cell adenocarcinoma Carcinoma ~20% survival rate at 10 µM MTT assay Not available Patent
SNU-601 Gastric signet ring cell adenocarcinoma Carcinoma 0% survival rate at 100 µM MTT assay Not available Patent

Hemolytic Activity  no haemolytic activity

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01794

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C122H218N30O21

Absent amino acids  ACDEFGHIMNQRSTVY

Common amino acids  K

Mass  278035

Pl  11.7

Basic residues  9

Acidic residues  0

Hydrophobic residues  8

Net charge  9

Boman Index  -1318

Hydrophobicity  -71

Aliphatic Index  136.5

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  5500

Absorbance 280nm  289.47

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US6800727B2

Patent Title  Peptides with increased + charge and hydrophobicity by substituting one or more amino acids of CA-MA peptide and pharmaceutical compositions containing thereof

Other Iinformation  Granted Patent; Family: 4s / 4ex; Family Jurisdictions: KR, US; Legal Status: Expired; Application No: 8141802; Filed: Feb 22, 2002; Published: Oct 5, 2004; Earliest Priority: Sep 19, 2001; Granted: Oct 5, 2004

Other Published ID  KR100438416B1  KR20030024961A  US6800727B2  




DRACP is developed by Dr.Zheng's team.